Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, announced financial results today for the fourth quarter and fiscal year ended
Pharma giants Merck, Sanofi & GSK announced their full-year results for 2014 this week, as did global AgroChemical multinational Syngenta. Syngenta reported sales of $15.1 billion USD, achieving their integrates
Thermo Fisher Scientific have announced their acquisition of ASI (Advanced Scientifics, Inc.) for a cash payment of $300 million USD as the company seeks to strengthen their bioproduction offerings. ASI
Roche delivers solid sales growth for the first nine months of 2014 Group sales up 5% at CER1, stable in Swiss francs 4% higher sales in Pharmaceuticals Division, with strong
Company terminates existing sales agreement with BlueWave Healthcare Consultants Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMC) technology for clinical diagnostics and scientific discovery, today outlined
Beckman Coulter has received U.S. Food and Drug Administration (FDA) 510(k) clearance on its Power Express high-speed automated sample processing system. Designed to meet the needs of the most demanding
BD To Acquire CareFusion For $12.2 Billion BD and CareFusion announced a definitive agreement under which BD will acquire CareFusion for $58.00 per share in cash and stock, or a
Perkin Elmer, a global leader focused on improving the health and safety of people and the environment, today reported financial results for the second quarter ended June 30, 2013. The
Agilent’s Electronic Measurement Business to be Distributed to Shareholders Through a Tax-Free Spinoff. From a strategic perspective, the division aims to increases the strategic flexibility of both standalone businesses. Highlights
Singulex, Inc., the leading provider of Single Molecule Counting (SMC™) technology for scientific discovery and clinical testing services, today announced it has secured a debt facility for up to $40
On October 11, 2013, Promega Corporation will host a grand opening celebration to unveil its new cGMP manufacturing facility, the Feynman Center, dedicated to serving customers who need molecular biology